15036

    0

    INFINIUM

    img img img img
    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    INFINIUM PHARMACHEM LTD Share Price Today

    INFINIUM PHARMACHEM LTD is currently trading at ₹205.05, down by ₹7.19 from the previous close. The stock touched an intraday high of ₹209.00 and a low of ₹205.05 during the latest trading session. Over the past one year, INFINIUM PHARMACHEM LTD has delivered a loss of 26.93%, while the stock has gained 3.92% in the last one month.

    INFINIUM PHARMACHEM LTD performance

    Today’s low Today’s high
    ₹ 205.05 ₹ 209.00
    ₹ 205.05
    52 week low 52 week high
    ₹ 189.40 ₹ 300.95
    ₹ 205.05
    Open Price ₹ 209.00
    Prev. Close ₹ 212.25
    Volume (Shares) 2000.00
    Total traded value ₹ 4.10
    Upper Circuit ₹ 222.85
    Lower Circuit ₹ 201.65
    info

    Investment Returns

    Over 1 Month 3.92% Over 3 Months 3.11% Over 6 Months -3.68% Over 1 Year -26.93%
    demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    INFINIUM PHARMACHEM LTD fundamentals


    • Market cap (Cr) 330.80
    • P/E Ratio (TTM) 33.01
    • Beta 0.47
    • Book Value / share 74.26
    • Return on equity 10.36%
    • EPS (TTM) 6.43
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) 0.00
    info icon alternate text
    • Market cap (Cr) [-]
    • P/E Ratio (TTM) [-]
    • Beta [-]
    • Book Value / share [-]
    • Return on equity [-]%
    • EPS (TTM) [-]
    • Dividend yield 0.00%
    • Net profit/quarter (Cr) [-]
    info icon alternate text

    INFINIUM PHARMACHEM LTD Financials

    • Key Results
    • Key Ratios
    • Balance sheet
    • Cash Flow
    • Competition
    Open financial information
    Revenue
    Net income
    Particulars MAR 2026 (Values in Cr)
    Revenue 156.45
    Operating Expense 144.34
    Net Profit 10.02
    Net Profit Margin (%) 6.40
    Earnings Per Share (EPS) 6.43
    EBITDA 18.37
    Effective Tax Rate (%) 25.90
    Particulars MAR 2025 (Values in Cr)
    Revenue 136.92
    Operating Expense 127.44
    Net Profit 8.47
    Net Profit Margin (%) 6.18
    Earnings Per Share (EPS) 5.82
    EBITDA 17.29
    Effective Tax Rate (%) 27.04
    Particulars MAR 2024 (Values in Cr)
    Revenue 122.36
    Operating Expense 109.13
    Net Profit 11.09
    Net Profit Margin (%) 9.06
    Earnings Per Share (EPS) 7.97
    EBITDA 19.05
    Effective Tax Rate (%) 25.37
    Particulars MAR 2023 (Values in Cr)
    Revenue 101.31
    Operating Expense 90.39
    Net Profit 9.15
    Net Profit Margin (%) 9.03
    Earnings Per Share (EPS) 18.00
    EBITDA 16.55
    Effective Tax Rate (%) 25.44
    Particulars MAR 2022 (Values in Cr)
    Revenue 74.04
    Operating Expense 67.56
    Net Profit 5.50
    Net Profit Margin (%) 7.42
    Earnings Per Share (EPS) 54.13
    EBITDA 9.65
    Effective Tax Rate (%) 25.64
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 70.25
    ROE % 11.58
    ROCE % 15.64
    Total Debt to Total Equity 0.38
    EBITDA Margin 13.73
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 42.24
    ROE % 28.28
    ROCE % 28.57
    Total Debt to Total Equity 0.50
    EBITDA Margin 14.80
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 44.39
    ROE % 55.06
    ROCE % 36.74
    Total Debt to Total Equity 1.45
    EBITDA Margin 15.23
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 128.88
    ROE % 66.43
    ROCE % 38.89
    Total Debt to Total Equity 1.64
    EBITDA Margin 11.06
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 69.09
    ROE % 48.40
    ROCE % 32.17
    Total Debt to Total Equity 1.72
    EBITDA Margin 7.91
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 67.84
    ROE % 10.36
    ROCE % 13.22
    Total Debt to Total Equity 0.33
    EBITDA Margin 12.64
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 41.50
    ROE % 27.91
    ROCE % 29.32
    Total Debt to Total Equity 0.43
    EBITDA Margin 15.57
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 42.69
    ROE % 53.43
    ROCE % 36.86
    Total Debt to Total Equity 1.42
    EBITDA Margin 16.34
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 123.45
    ROE % 56.12
    ROCE % 34.43
    Total Debt to Total Equity 1.69
    EBITDA Margin 13.03
    Particulars MAR 2021 (Values in Cr)
    Book Value / Share 69.31
    ROE % 47.85
    ROCE % 31.75
    Total Debt to Total Equity 1.70
    EBITDA Margin 10.14
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 34.84
    Total Assets 198.38
    Total Liabilities 198.38
    Total Equity 124.79
    Share Outstanding 1
    Price to Book Ratio 3.57
    Return on Assets (%) 4.10
    Return on Capital (%) 4.61
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 11.91
    Total Assets 85.45
    Total Liabilities 85.45
    Total Equity 60.23
    Share Outstanding 1
    Price to Book Ratio 5.52
    Return on Assets (%) 13.22
    Return on Capital (%) 15.81
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 5.98
    Total Assets 70.61
    Total Liabilities 70.61
    Total Equity 23.78
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 13.43
    Return on Capital (%) 17.9
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 5.45
    Total Assets 58.99
    Total Liabilities 58.99
    Total Equity 13.92
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 10.34
    Return on Capital (%) 16.76
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.98
    Total Assets 34.18
    Total Liabilities 34.18
    Total Equity 7.21
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 7.97
    Return on Capital (%) 15.37
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 33.28
    Total Assets 166.12
    Total Liabilities 166.12
    Total Equity 105.71
    Share Outstanding 1
    Price to Book Ratio 3.57
    Return on Assets (%) 5.09
    Return on Capital (%) 5.61
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 8.17
    Total Assets 77.74
    Total Liabilities 77.74
    Total Equity 57.75
    Share Outstanding 1
    Price to Book Ratio 5.52
    Return on Assets (%) 14.26
    Return on Capital (%) 16.89
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 3.31
    Total Assets 60.41
    Total Liabilities 60.41
    Total Equity 21.69
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 15.14
    Return on Capital (%) 19.14
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.54
    Total Assets 49.05
    Total Liabilities 49.05
    Total Equity 12.54
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 11.21
    Return on Capital (%) 15.69
    Particulars MAR 2021 (Values in Cr)
    Cash & Short Term Investments 1.23
    Total Assets 30.80
    Total Liabilities 30.80
    Total Equity 7.04
    Share Outstanding 0
    Price to Book Ratio 0.00
    Return on Assets (%) 8.82
    Return on Capital (%) 15.49
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.56
    Cash from Operations -25.26
    Cash from Investing -27.24
    Cash from Financing 79.29
    Net change in Cash 22.92
    Free Cash Flow -20.00
    Particulars MAR 2024 (Values in Cr)
    Net Income 15.21
    Cash from Operations -9.37
    Cash from Investing -3.79
    Cash from Financing 22.76
    Net change in Cash 5.93
    Free Cash Flow -5.85
    Particulars MAR 2023 (Values in Cr)
    Net Income 12.95
    Cash from Operations 11.70
    Cash from Investing -4.95
    Cash from Financing -3.10
    Net change in Cash 0.52
    Free Cash Flow 19.17
    Particulars MAR 2022 (Values in Cr)
    Net Income 8.63
    Cash from Operations 13.75
    Cash from Investing -6.63
    Cash from Financing -1.70
    Net change in Cash 3.46
    Free Cash Flow 18.47
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.76
    Cash from Operations 8.33
    Cash from Investing -4.99
    Cash from Financing -1.15
    Net change in Cash 1.13
    Free Cash Flow 13.41
    Particulars MAR 2025 (Values in Cr)
    Net Income 11.60
    Cash from Operations -22.69
    Cash from Investing -23.14
    Cash from Financing 74.20
    Net change in Cash 25.11
    Free Cash Flow -18.28
    Particulars MAR 2024 (Values in Cr)
    Net Income 14.86
    Cash from Operations -11.38
    Cash from Investing -3.29
    Cash from Financing 23.18
    Net change in Cash 4.86
    Free Cash Flow -8.06
    Particulars MAR 2023 (Values in Cr)
    Net Income 12.26
    Cash from Operations 10.44
    Cash from Investing -2.58
    Cash from Financing -2.99
    Net change in Cash 1.77
    Free Cash Flow 15.09
    Particulars MAR 2022 (Values in Cr)
    Net Income 7.40
    Cash from Operations 11.04
    Cash from Investing -7.17
    Cash from Financing -1.65
    Net change in Cash 0.30
    Free Cash Flow 15.74
    Particulars MAR 2021 (Values in Cr)
    Net Income 3.75
    Cash from Operations 7.86
    Cash from Investing -4.59
    Cash from Financing -1.12
    Net change in Cash 1.10
    Free Cash Flow 12.46
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 13.24 1.55 245.46 23.12 38.85
    BLISS GVS PHARMA LTD 511.55 41.12 4.54 5425.31 118.35 552.90
    CIPLA LTD. 1452.35 30.82 3.40 117327.41 1165.55 1672.20
    FERMENTA BIOTECH LTD. 369.50 16.30 2.67 1087.47 256.40 401.20
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 32.03 22.40 4.12 245.46 23.12 38.85
    AMRUTAJAN HEALTH LTD 538.95 24.16 4.20 1558.14 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8200.05 107.09 23.48 20500.13 7630.00 9850.00
    BLISS GVS PHARMA LTD 511.55 55.30 4.69 5425.31 118.35 552.90

    INFINIUM PHARMACHEM LTD shareholding pattern

    Holding
    34.87%
    64.91%
    0.21%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    INFINIUM PHARMACHEM LTD Technicals Summary

    • EMA & SMA
    • Resistance and Support
    • Delivery and Volume
    • Beta
    • Price Change Analysis
    212.25 0.00 redarrow
    red-green-graph indicator
    4 Bearish
    12 Bullish
    • 5 Days 210.60
    • 26 Days 208.20
    • 10 Days 209.00
    • 50 Days 209.00
    • 12 Days 208.70
    • 100 Days 213.20
    • 20 Days 208.20
    • 200 Days 224.70
    210.27 PIVOT
    First Support 208.63 First Resistance 213.53 Second Support 205.37 Second Resistance 215.17 Third Support 203.73 Third Resistance 218.43
    RSI 53.48 ADX 39.61 MACD 0.48 Williams % R -35.68 Commodity Channel Index (CCI) 53.36
    Date 2026-07-07 Week 4000.00 Same Day 1000.00 Month 5452.00
    1 Year 0.48 3 Year 0.50
    Over 1 Month
    3.92% down
    Over 1 Year
    -26.93% down
    Over 3 Months
    3.11% down
    Over 3 Years
    14.14% down
    Over 6 Months
    -3.68% down
    Over 5 Years
    0.00% down

    INFINIUM PHARMACHEM LTD Corporate Actions

    Ex-Date Ex-Bonus Ratio
    13 Sep 2023 13 Sep 2023 1:1

    Top Gainers

    Top Losers

    stock
    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Infinium Pharmachem Ltd?

    Answer Field

    Infinium Pharmachem Ltd share price is for NSE ₹ 205.05 & for BSE ₹ 0.00 as on Jul 10 2026 10:09 AM.

    What is the Market Cap of Infinium Pharmachem Ltd Share?

    Answer Field

    The market cap of Infinium Pharmachem Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Jul 10 2026 10:09 AM.

    What is the 52 Week High and Low of Infinium Pharmachem Ltd?

    Answer Field

    The 52 Week High and Low of Infinium Pharmachem Ltd for NSE is ₹ 300.95 and ₹ 189.40 and for BSE is ₹ 0.00 and ₹ 0.00.

    What is 1 year return for Infinium Pharmachem Ltd?

    Answer Field

    The 1 year returns on the stock has been -28.05%.

    What is the P/E Ratio of Infinium Pharmachem Ltd Share?

    Answer Field

    As on Jul 10 2026 10:09 AM the price-to-earnings (PE) ratio for Infinium Pharmachem Ltd share is 33.01.

    What is the PB ratio of Infinium Pharmachem Ltd Share?

    Answer Field

    As on Jul 10 2026 10:09 AM, the price-to-book (PB) ratio for Infinium Pharmachem Ltd share is 74.26.

    How to Buy Infinium Pharmachem Ltd Share?

    Answer Field

    You can trade in Infinium Pharmachem Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Infinium Pharmachem Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Infinium Pharmachem Ltd shares on the Bajaj Broking app, follow these steps:

    • Login to the Bajaj Broking App

    • Click on the Search Icon

    • Search “Infinium Pharmachem Ltd”

    • Click on the BUY icon

    • Place a buy order specifying the desired quantity of shares.

    • Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59
    banner-icon

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |